ARQT
Arcutis Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$23.90
+1.01%Forward multiples
Based on analyst estimates
- P/E forward
- 30.32x
- P/E 2026E
- 50.05x
- P/E 2027E
- 18.47x
- P/E 2028E
- 11.43x
- P/S forward
- 4.98x
Trailing multiples
Trailing twelve months
- P/E TTM
- 108.24x
- PEG TTM
- 0.42x
- Price / book
- 13.62x
- Price / sales
- 6.47x
- Price / cash flow
- 76.42x
Enterprise value
- Enterprise value
- $2.9B
- EV / sales
- 6.21x
- EV / EBITDA
- 65.25x
- EV / EBIT
- 84.07x
- Market cap
- $3.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026